285 related articles for article (PubMed ID: 30115681)
41. Cloning and functional characterization of IRAK1 from rainbow trout (Oncorhynchus mykiss).
Yang YC; Chen SN; Gan Z; Huang L; Nie P
Dev Comp Immunol; 2021 Jan; 114():103780. PubMed ID: 32745481
[TBL] [Abstract][Full Text] [Related]
42. MyD88 Death-Domain Oligomerization Determines Myddosome Architecture: Implications for Toll-like Receptor Signaling.
Moncrieffe MC; Bollschweiler D; Li B; Penczek PA; Hopkins L; Bryant CE; Klenerman D; Gay NJ
Structure; 2020 Mar; 28(3):281-289.e3. PubMed ID: 31995744
[TBL] [Abstract][Full Text] [Related]
43. Complete dependence on IRAK4 kinase activity in TLR2, but not TLR4, signaling pathways underlies decreased cytokine production and increased susceptibility to Streptococcus pneumoniae infection in IRAK4 kinase-inactive mice.
Pennini ME; Perkins DJ; Salazar AM; Lipsky M; Vogel SN
J Immunol; 2013 Jan; 190(1):307-16. PubMed ID: 23209321
[TBL] [Abstract][Full Text] [Related]
44. Characterization of the interleukin 1 receptor-associated kinase 4 (IRAK4)-encoding gene in salmonid fish: the functional copy is rearranged in Oncorhynchus mykiss and that factor can impair TLR signaling in mammalian cells.
Brietzke A; Goldammer T; Rebl H; Korytář T; Köllner B; Yang W; Rebl A; Seyfert HM
Fish Shellfish Immunol; 2014 Jan; 36(1):206-14. PubMed ID: 24239597
[TBL] [Abstract][Full Text] [Related]
45. Regulation of interleukin-1- and lipopolysaccharide-induced NF-kappaB activation by alternative splicing of MyD88.
Janssens S; Burns K; Tschopp J; Beyaert R
Curr Biol; 2002 Mar; 12(6):467-71. PubMed ID: 11909531
[TBL] [Abstract][Full Text] [Related]
46. A small molecule potent IRAK4 inhibitor abrogates lipopolysaccharide-induced macrophage inflammation in-vitro and in-vivo.
Choudhary SA; Patra D; Sinha A; Mazumder S; Pant R; Chouhan R; Jha AN; Prusty BM; Manna D; Das SK; Tikoo K; Pal D; Dasgupta S
Eur J Pharmacol; 2023 Apr; 944():175593. PubMed ID: 36804543
[TBL] [Abstract][Full Text] [Related]
47. The IL-1R/TLR signaling pathway is essential for efficient CD8
Ma Z; Liu J; Wu W; Zhang E; Zhang X; Li Q; Zelinskyy G; Buer J; Dittmer U; Kirschning CJ; Lu M
Cell Mol Immunol; 2017 Dec; 14(12):997-1008. PubMed ID: 28757610
[TBL] [Abstract][Full Text] [Related]
48. IRAK4 kinase activity controls Toll-like receptor-induced inflammation through the transcription factor IRF5 in primary human monocytes.
Cushing L; Winkler A; Jelinsky SA; Lee K; Korver W; Hawtin R; Rao VR; Fleming M; Lin LL
J Biol Chem; 2017 Nov; 292(45):18689-18698. PubMed ID: 28924041
[TBL] [Abstract][Full Text] [Related]
49. Modulation of Toll-interleukin 1 receptor mediated signaling.
Li X; Qin J
J Mol Med (Berl); 2005 Apr; 83(4):258-66. PubMed ID: 15662540
[TBL] [Abstract][Full Text] [Related]
50. IRAK1 and IRAK4 promote phosphorylation, ubiquitination, and degradation of MyD88 adaptor-like (Mal).
Dunne A; Carpenter S; Brikos C; Gray P; Strelow A; Wesche H; Morrice N; O'Neill LA
J Biol Chem; 2010 Jun; 285(24):18276-82. PubMed ID: 20400509
[TBL] [Abstract][Full Text] [Related]
51. Selective interleukin-1 receptor-associated kinase 4 inhibitors for the treatment of autoimmune disorders and lymphoid malignancy.
Kelly PN; Romero DL; Yang Y; Shaffer AL; Chaudhary D; Robinson S; Miao W; Rui L; Westlin WF; Kapeller R; Staudt LM
J Exp Med; 2015 Dec; 212(13):2189-201. PubMed ID: 26621451
[TBL] [Abstract][Full Text] [Related]
52. A low molecular weight mimic of the Toll/IL-1 receptor/resistance domain inhibits IL-1 receptor-mediated responses.
Bartfai T; Behrens MM; Gaidarova S; Pemberton J; Shivanyuk A; Rebek J
Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7971-6. PubMed ID: 12799462
[TBL] [Abstract][Full Text] [Related]
53. Interleukin-1 Receptor-Associated Kinase 1/4 as a Novel Target for Inhibiting Neointimal Formation After Carotid Balloon Injury.
Bai S; Li D; Zhou Z; Cao J; Xu T; Zhang X; Wang Y; Guo J; Zhang Y
J Atheroscler Thromb; 2015; 22(12):1317-37. PubMed ID: 26310493
[TBL] [Abstract][Full Text] [Related]
54. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction.
Fitzgerald KA; Palsson-McDermott EM; Bowie AG; Jefferies CA; Mansell AS; Brady G; Brint E; Dunne A; Gray P; Harte MT; McMurray D; Smith DE; Sims JE; Bird TA; O'Neill LA
Nature; 2001 Sep; 413(6851):78-83. PubMed ID: 11544529
[TBL] [Abstract][Full Text] [Related]
55. IRAK4 dimerization and trans-autophosphorylation are induced by Myddosome assembly.
Ferrao R; Zhou H; Shan Y; Liu Q; Li Q; Shaw DE; Li X; Wu H
Mol Cell; 2014 Sep; 55(6):891-903. PubMed ID: 25201411
[TBL] [Abstract][Full Text] [Related]
56. Decreased expressions of Toll-like receptor 9 and its signaling molecules in chronic hepatitis B virus-infected patients.
Sajadi SM; Mirzaei V; Hassanshahi G; Khorramdelazad H; Daredor HY; Hosseini SM; Moogooi M; Ravary A; Arababadi MK; Kennedy D
Arch Pathol Lab Med; 2013 Nov; 137(11):1674-9. PubMed ID: 24168509
[TBL] [Abstract][Full Text] [Related]
57. Experimental and natural infections in MyD88- and IRAK-4-deficient mice and humans.
von Bernuth H; Picard C; Puel A; Casanova JL
Eur J Immunol; 2012 Dec; 42(12):3126-35. PubMed ID: 23255009
[TBL] [Abstract][Full Text] [Related]
58. Mechanism of MyD88S mediated signal termination.
Pustelny K; Kuska K; Gorecki A; Musielak B; Dobosz E; Wladyka B; Koziel J; Czarna A; Holak T; Dubin G
Cell Commun Signal; 2022 Jan; 20(1):10. PubMed ID: 35057808
[TBL] [Abstract][Full Text] [Related]
59. Association of polymorphisms in the MyD88, IRAK4 and TRAF6 genes and susceptibility to type 2 diabetes mellitus and diabetic nephropathy in a southern Han Chinese population.
Guo C; Zhang L; Nie L; Zhang N; Xiao D; Ye X; Ou M; Liu Y; Zhang B; Wang M; Lin H; Yang G; Jing C
Mol Cell Endocrinol; 2016 Jul; 429():114-9. PubMed ID: 27062898
[TBL] [Abstract][Full Text] [Related]
60. Pellino-1 Positively Regulates Toll-like Receptor (TLR) 2 and TLR4 Signaling and Is Suppressed upon Induction of Endotoxin Tolerance.
Murphy M; Xiong Y; Pattabiraman G; Qiu F; Medvedev AE
J Biol Chem; 2015 Jul; 290(31):19218-32. PubMed ID: 26082489
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
